Conference item
Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease
- Abstract:
-
Importance: Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.
Objective: To examine the clinical phenotypes, treatment responses, and outcomes of children with relapsing MOG-Ab-associated disease.
Design, Setting, and Participants:
Expand abstract
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- American Medical Association Publisher's website
- Journal:
- JAMA Neurology
- Volume:
- 75
- Issue:
- 4
- Pages:
- 478-487
- Host title:
- JAMA Neurology
- Publication date:
- 2018-01-05
- Acceptance date:
- 2017-10-19
- Event location:
- United States
- DOI:
- EISSN:
-
2168-6157
- ISSN:
-
2168-6149
- Pmid:
-
29305608
- Source identifiers:
-
813529
Item Description
- Keywords:
- Pubs id:
-
pubs:813529
- UUID:
-
uuid:230e3337-d3fc-4877-b416-4a1f520ec8b2
- Local pid:
- pubs:813529
- Deposit date:
- 2019-10-07
Terms of use
- Copyright date:
- 2018
- Notes:
- © 2018 American Medical Association. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record